cefaclor anhydrous has been researched along with Lung Diseases, Obstructive in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dubois, J; Fong, IW; Grossman, R; Laforge, J; Small, D; Zakhari, R | 1 |
Butler, T; Phillips, H; Todd, WM; Van Hook, CJ | 1 |
Akman, M; Arseven, O; Aydin Tosun, G; Erelel, M; Erk, M; Göylüsün, V; Gür, A; Ilvan, A; Koşar, F; Müsellim, B; Oztürk, S; Soysal, F; Türker, H; Tutluoglu, B; Umut, S; Unutmaz, S; Vahapoglu, H; Yildirim, N; Yilmaz Kuyucu, T; Yilmaz, N | 1 |
Braschi, R; Moreo, G; Nani, M; Remotti, G; Sardi, C | 1 |
4 trial(s) available for cefaclor anhydrous and Lung Diseases, Obstructive
Article | Year |
---|---|
Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Topics: Bronchitis; Cefaclor; Clarithromycin; Female; Haemophilus influenzae; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia; Streptococcus pneumoniae | 1995 |
A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults.
Topics: Acute Disease; Adult; Aged; Bacteria; Cefaclor; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Drug Tolerance; Female; Humans; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Prodrugs; United States | 1993 |
Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group.
Topics: Ampicillin; Anti-Infective Agents; Azithromycin; Cefaclor; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Sulbactam; Treatment Outcome | 1999 |
[Comparison of an antibiotic combination (amoxicillin + clavulanic acid) and cefaclor in the treatment of acute or flare-ups of chronic bronchopneumopathies].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Asthma; Bronchitis; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1988 |